← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Valley Fever Solutions, Inc.
Tucson, AZ
$5,152,362
Total funding
2
Grants
Funding over time
peak $3M · FY2010–18$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$5,152,362 · 2
By mechanism
RC3$2,999,834 · 1
U01$2,152,528 · 1
Investigators at Valley Fever Solutions, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Nikkomycin Z treatment of early coccidioidal pneumonia: Phase II clinical trial$2,999,834
RC3 · FY2010 · MD
Nikkomycin Z treatment of primary pneumonia due to Coccidioides$864,797
U01 · FY2015 · AI
Nikkomycin Z treatment of primary pneumonia due to Coccidioides$859,330
U01 · FY2016 · AI
Nikkomycin Z treatment of primary pneumonia due to Coccidioides$211,459
U01 · FY2014 · AI
Nikkomycin Z treatment of primary pneumonia due to Coccidioides$190,126
U01 · FY2018 · AI
Nikkomycin Z treatment of primary pneumonia due to Coccidioides$26,816
U01 · FY2015 · AI